Purification of Definitive Endoderm Generated from Pluripotent Stem Cells by Magnetic Cell Sorting

2017 ◽  
Vol 40 (1) ◽  
Author(s):  
Ulf Diekmann ◽  
Claudia Davenport ◽  
Jasmin Kresse ◽  
Ortwin Naujok
Blood ◽  
1998 ◽  
Vol 92 (8) ◽  
pp. 2886-2892 ◽  
Author(s):  
Kohki Saitoh ◽  
Ikuo Miura ◽  
Naoto Takahashi ◽  
Akira B. Miura

Myelodysplastic syndrome (MDS) is believed to be a stem-cell disorder involving cytopenia and dysplastic changes in three hematopoietic lineages. However, the involvement of pluripotent stem cells and progenitor cells has not been clarified conclusively. To address this issue, we used fluorescence in situ hybridization (FISH) of blood and bone marrow (BM) smears for mature cells and FISH of cells sorted by fluorescence-activated cell sorting for progenitor cells. Seven patients with MDS associated with trisomy 8 were studied. FISH showed +8 in granulocytes, monocytes, and erythroblasts, but not in lymphocytes. Sorted cells of T (CD3+), B (CD19+), and NK cells (CD3−CD56+) from peripheral blood did not contain +8, nor did CD34+ subpopulations from BM including B (CD34+CD19+), T/NK (CD34+CD7+) progenitors, and pluripotent stem cells (CD34+Thy1+). The +8 chromosome abnormality was identified in stem cells only at the level of colony-forming unit of granulocyte-erythrocyte-macrophage-megakaryocyte (CFU-GEMM; CD34+CD33+). It may thus be concluded that cells affected by trisomy 8 in the context of MDS are at the CFU-GEMM level and that cells of lymphoid lineage are not involved. These results provide new insights into the biology of MDS and suggest that intensive chemotherapy and autologous BM transplantation may become important therapeutic strategies. © 1998 by The American Society of Hematology.


2012 ◽  
Vol 215 (3) ◽  
pp. S93-S94
Author(s):  
Shaun Michael Kunisaki ◽  
Guihua Jiang ◽  
Luis G. Villa-Diaz ◽  
Kathy Sue O'Shea ◽  
Paul H. Krebsbach

PLoS ONE ◽  
2013 ◽  
Vol 8 (5) ◽  
pp. e64291 ◽  
Author(s):  
Hidefumi Iwashita ◽  
Nobuaki Shiraki ◽  
Daisuke Sakano ◽  
Takashi Ikegami ◽  
Masanobu Shiga ◽  
...  

2017 ◽  
Vol 312 (5) ◽  
pp. C573-C582 ◽  
Author(s):  
Taku Kaitsuka ◽  
Kohei Kobayashi ◽  
Wakako Otsuka ◽  
Takuya Kubo ◽  
Farzana Hakim ◽  
...  

Artificially generated pancreatic β-cells from pluripotent stem cells are expected for cell replacement therapy for type 1 diabetes. Several strategies are adopted to direct pluripotent stem cells toward pancreatic differentiation. However, a standard differentiation method for clinical application has not been established. It is important to develop more effective and safer methods for generating pancreatic β-cells without toxic or mutagenic chemicals. In the present study, we screened several endogenous factors involved in organ development to identify the factor, which induced the efficiency of pancreatic differentiation and found that treatment with erythropoietin (EPO) facilitated the differentiation of mouse embryonic stem cells (ESCs) into definitive endoderm. At an early stage of differentiation, EPO treatment significantly increased Sox17 gene expression, as a marker of the definitive endoderm. Contrary to the canonical function of EPO, it did not affect the levels of phosphorylated JAK2 and STAT5, but stimulated the phosphorylation of ERK1/2 and Akt. The MEK inhibitor U0126 significantly inhibited EPO-induced Sox17 expression. The differentiation of ESCs into definitive endoderm is an important step for the differentiation into pancreatic and other endodermal lineages. This study suggests a possible role of EPO in embryonic endodermal development and a new agent for directing the differentiation into endodermal lineages like pancreatic β-cells.


2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Ulf Diekmann ◽  
Hanna Wolling ◽  
Rabea Dettmer ◽  
Isabell Niwolik ◽  
Ortwin Naujok ◽  
...  

Biomaterials ◽  
2020 ◽  
Vol 253 ◽  
pp. 120060
Author(s):  
Tzu-Cheng Sung ◽  
Huan Chiao Su ◽  
Qing-Dong Ling ◽  
S. Suresh Kumar ◽  
Yung Chang ◽  
...  

2006 ◽  
Vol 18 (2) ◽  
pp. 177
Author(s):  
T. Mitani ◽  
Y. Tanaka ◽  
Y. Ozaki ◽  
K. Saeki ◽  
K. Kato ◽  
...  

Recently, studies on cell surface markers of spermatogonia in combination with germ cell transplantation techniques have made possible the functional analysis of germline stem cells (GS cells). The GS cells are downstream of the stem cells such as ES cells and embryonic germ cells (EG cells), which are derived from primordial germ cells (PGCs). Therefore, GS cells are expected to be useful in the production of genetically modified animals. In this study, we examined the enrichment and cultivation of mouse GS cells by magnetic cell sorting (MACS). Testicular cell suspensions were collected from C57BL/6J cryptorchid adult testes at 2 to 3 months after surgery and ICR pup (6 to 8 dpp) testes. They were digested by 0.1% collagenase followed by 0.25% trypsin with gentle shaking. Dissociated cell suspensions were filtrated through a glass-wool column followed by a Falcon cell strainer (40-�m mesh). They were then treated with biotin-conjugated anti-mouse CD9 antibody, whose antigen, CD9, is localized on the GS cell surface, followed by the streptavidin-microbeads treatment. The cell suspension was passed through a MACS-separation column. In Experiment I, MACS-treated fractions were analyzed by flow cytometry (FCM) on the rates of recovery and enrichment and their cellular characteristics. In Experiment II, CD9-positive (CD9+) cells were cultured on gelatin-coated MultiDish (176740, Nunc) with 4-5 � 105 cells/well in StemPro34-SFM supplemented with 1% fetal bovine serum, leukemia inhibitory factor, GDNF, bFGF, EGF, insulin, transferrin, putrescine, MEM vitamin solution, MEM-NEAA and some other reagents at 32�C or 37�C under 5% CO2 in air. They were examined for their proliferation and cytological changes such as CD9, �6-integrin and Oct-1 expression by immunohistochemistry. In Experiment I, MACS selection effectively enriched CD9+ cells from mouse testes. However, FCM analysis revealed that the CD9-negative (CD9-) cells partially remained in MACS-selected fraction from cryptorchid adult testes. In contrast, the CD9+ subpopulation could be successfully separated from CD9- subpopulation from pup testes. Therefore CD9+ subpopulation from pup testes was used for the following cultivation. In Experiment II, the cells proliferated in the first few days in suspension. Then they attached to the dish and formed colonies after 5 days or 3 days of culture at 32�C or 37�C, respectively. Immunohistochemical analysis showed that the cells maintained the expression of CD9 for at least 14 days, but their expression of �6-integrin gradually diminished. It was demonstrated by immunohistochemistry and FCM analysis that the cells in colonies expressed Oct-1, and its expression level was stronger in culture at 37�C than at 32�C. These findings indicate that the CD9+ cells collected from mouse pup testes have stem cell properties. This work was supported by the Wakayama Prefecture Collaboration of Regional Entities for the Advanced Technological Excellence, JST; by a Grant-in-Aid for the 21st Century Center of Excellence Program of the MEXT, Japan; and by a Grant-in Aid for Scientific Research from the Japan Society for the Promotion of Science.


2012 ◽  
Vol 111 (suppl_1) ◽  
Author(s):  
Kiwon Ban ◽  
Brian Wile ◽  
Sangsung Kim ◽  
Jaemin Byun ◽  
Talib Saafir ◽  
...  

Background: While various methods for generating cardiomyocytes (CMs) from pluripotent stem cells (PSCs) including both embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) have been reported, all available methods are only allowed to produce heterogeneous population of CM mixed with non-CM cells. Therefore, strategies to enrich pure CMs for scientific and clinical applications have been highly required. Hence, we developed a novel system in which CMs can be purified by cardiac specific molecular beacons (MBs). MBs are dual-labeled antisense nano-scale probes that emit a fluorescence signal when hybridized to target mRNAs. We hypothesized that MBs targeted to CM specific mRNAs can identify CMs and allow isolation of purified CMs by fluorescence-activated cell sorting (FACS). Methods and results: Five MBs targeting distinct sites on either cardiac troponin T (cTNT) or α/β myosin heavy chain (α/βMHC) were designed and characterized in various cell types. To find the optimal MB that can selectively identifying CMs, each MB was delivered into HL-1 CMs, an immortalized mouse CM cell line, smooth muscle cells, endothelial cells, mouse ESCs and fibroblasts and its specificity was determined by flow cytometry. As a result, two MBs identified MB+ cells up to 98% from HL-1 CMs but lower than 10% of the non-CM cells suggesting these MBs are CM specific. Subsequently, the selected MBs were delivered into both mouse and human PSCs derived CMs and 41 to 49% of the cells were identified as an MB+ population. Interestingly, the rate of MB+ cells was similar to CM quantification determined by cTNT intracellular flow cytometry. Finally, we determined whether cell sorting with cardiac-specific MBs can enrich CMs from the heterogeneous mouse and human PSC cultures and found that ∼97% of MB-based sorted CMs expressed cTNT. These enriched cells were further cultured and their CM identity was verified by immunocytochemistry and qRT-PCR analysis. Ca2+ transient analysis further confirmed that these purified CMs displayed functional CM characteristics Conclusion: Using cardiac specific MBs, we were able to obtain highly purified CMs. These purified CMs and the system can be highly useful for clinical applications as well as drug discovery.


Sign in / Sign up

Export Citation Format

Share Document